19.12.2013 16:23:31

Press Release: MagForce AG Installs NanoActivator(R) at the Kiel University Hospital

MagForce AG / MagForce AG Installs NanoActivator(R) at the Kiel University Hospital . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Berlin, Germany, December 19, 2013 - MagForce AG (Frankfurt, Xetra: MF6), a medical technology company that focuses on the field of oncology and is a leader in the nanotechnology sector, today announced the installation of the third NanoActivator(R) . The NanoActivator(R) was installed as part of the preparations for the new glioblastoma study at the Kiel University Hospital.

About MagForce AG'

MagForce AG is a leading medical device company in the field of nanomedicine in oncology, listed in the entry standard (MF6). The Company's proprietary, NanoTherm(R) therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm(R) , NanoPlan(R) , and NanoActivator(R) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm(R) , NanoPlan(R) , and NanoActivator(R) are trademarks of MagForce AG in selected countries. For more information, please visit www.magforce.com.

Disclaimer

This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated.

For further information:

Anne Hennecke

MC Services AG

anne.hennecke@mc-services.eu

T +49 211 529252 22

F +49 211 529252 29

M +49 151 12 555 759

MagForce_Press Release_December 19, 2013: http://hugin.info/143761/R/1751288/590311.pdf

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: MagForce AG via Globenewswire

HUG#1751288

--- End of Message ---

MagForce AG

Max-Planck-Strasse 3 Berlin Germany

WKN: A0HGQF;ISIN: DE000A0HGQF5;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Börse Berlin,

Freiverkehr in Börse Düsseldorf,

Entry Standard in Frankfurter Wertpapierbörse,

XETRA in Frankfurter Wertpapierbörse;

http://www.magforce.de/english/home1.html (END) Dow Jones Newswires

   December 19, 2013 09:51 ET (14:51 GMT)- - 09 51 AM EST 12-19-13

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu MagForce AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu MagForce AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

MagForce AG 0,00 0,00% MagForce AG

Indizes in diesem Artikel

NASDAQ Comp. 19 926,72 0,12%